98 related articles for article (PubMed ID: 6259386)
21. [Molecular biology criteria for functioning of the genome of Rous sarcoma virus in transformed rat XC cells].
Kiselev FL; Galetskiĭ SA; Mazurenko NN; Asanova AA; Zborovskaia IB
Mol Biol (Mosk); 1982; 16(1):66-76. PubMed ID: 6280033
[TBL] [Abstract][Full Text] [Related]
22. Myogenin expression is necessary for commitment to differentiation and is closely related to src tyrosine kinase activity in quail myoblasts transformed with Rous sarcoma virus.
Hirayama E; Isobe A; Okamoto H; Nishioka M; Kim J
Eur J Cell Biol; 1997 Feb; 72(2):133-41. PubMed ID: 9157009
[TBL] [Abstract][Full Text] [Related]
23. [Sarc-specific protein kinase activity of the ribosomal fraction of cells transformed by Rous sarcoma virus].
Perevozchikov AP; Kniazev PG; Iakovlev VN; Pluzhnikova GF; Belokhvostov AS
Dokl Akad Nauk SSSR; 1982; 266(5):1277-80. PubMed ID: 6291887
[No Abstract] [Full Text] [Related]
24. [Resistance to Rous tumor cells in mice induced by Rous virus].
Kriukova IN; Babkova OV; Obukh IB
Vopr Onkol; 1971; 17(8):81-5. PubMed ID: 4332398
[No Abstract] [Full Text] [Related]
25. Dissection of the antigenic determinants expressed on the cell surface of RSV-transformed fibroblasts by monoclonal antibodies.
Ferracini R; Prat M; Comoglio PM
Int J Cancer; 1982 Apr; 29(4):477-81. PubMed ID: 6177648
[TBL] [Abstract][Full Text] [Related]
26. Characterization of tumors induced in adult Macaca mulata monkeys with Carr-Zilber strain of Rous sarcoma virus.
Adgighitov FI; Gubeladze DA; Lapin BA; Hlozánek I; Sovová V; Cerná H
Neoplasma; 1980; 27(2):159-64. PubMed ID: 6248800
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a Gp85-related glycoprotein in cells transformed by the Bryan high titer strain of Rous sarcoma virus.
Pauli G; Fleischer B
Arch Virol; 1981; 68(3-4):173-87. PubMed ID: 6168244
[TBL] [Abstract][Full Text] [Related]
28. Rous sarcoma virus transformed cells are resistant to cyclic AMP.
Roth CW; Singh T; Pastan I; Gottesman MM
J Cell Physiol; 1982 Apr; 111(1):42-8. PubMed ID: 6282904
[TBL] [Abstract][Full Text] [Related]
29. Individually distinct tumor-specific cell surface antigen identified by monoclonal antibody on a Rous sarcoma virus-induced mouse tumor.
Kuzumaki N; Minakawa H; Miyazaki T; Haraguchi S; Matsuo T; Yoshida TO
J Natl Cancer Inst; 1982 Aug; 69(2):527-30. PubMed ID: 6287079
[TBL] [Abstract][Full Text] [Related]
30. A new defective retroviral vector system based on the Bryan strain of Rous sarcoma virus.
Boerkoel CF; Federspiel MJ; Salter DW; Payne W; Crittenden LB; Kung HJ; Hughes SH
Virology; 1993 Aug; 195(2):669-79. PubMed ID: 8393241
[TBL] [Abstract][Full Text] [Related]
31. Transplantation resistance to a Rous sarcoma virus-induced tumor in mice immunized with v-src protein.
Kuzumaki N; Fujita H; Dosaka H; Katabami M; Levinson AD
J Natl Cancer Inst; 1988 Aug; 80(12):959-62. PubMed ID: 2840516
[TBL] [Abstract][Full Text] [Related]
32. Sodium and rubidium uptake in cells transformed by Rous sarcoma virus.
Bader JP; Okazaki T; Brown NR
J Cell Physiol; 1981 Feb; 106(2):235-43. PubMed ID: 6260819
[TBL] [Abstract][Full Text] [Related]
33. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
Tjuvajev JG; Chen SH; Joshi A; Joshi R; Guo ZS; Balatoni J; Ballon D; Koutcher J; Finn R; Woo SL; Blasberg RG
Cancer Res; 1999 Oct; 59(20):5186-93. PubMed ID: 10537296
[TBL] [Abstract][Full Text] [Related]
34. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
Wenkel H; Chen PW; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
[TBL] [Abstract][Full Text] [Related]
35. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
36. Effect of orthovanadate on commitment of avian myoblasts transformed with Rous sarcoma virus to myogenic differentiation.
Hase H; Isobe A; Kim J
Eur J Cell Biol; 1995 Nov; 68(3):313-22. PubMed ID: 8603684
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptors in Rous sarcoma virus-transformed cells of different hosts.
Sovová V; Fidlerová H; Trnka D; Sloncová E
Folia Biol (Praha); 1994; 40(5):291-9. PubMed ID: 7895858
[TBL] [Abstract][Full Text] [Related]
38. Studies on rous sarcoma virus in mice. II. Clonal analysis of cell populations of the SR-RSV-induced mouse ascites sarcoma (SR-C3H/HE ascites).
Takeuchi M; Hino S; Yamamoto T
Jpn J Exp Med; 1967 Apr; 37(2):107-20. PubMed ID: 4294688
[No Abstract] [Full Text] [Related]
39. Submolecular recognition profiles in two mouse strains of non-protective and protective antibodies against botulinum neurotoxin A.
Atassi MZ; Dolimbek GS; Deitiker PR; Aoki KR; Dolimbek BZ
Mol Immunol; 2005 Aug; 42(12):1509-20. PubMed ID: 15950744
[TBL] [Abstract][Full Text] [Related]
40. Experimental gene therapy against subcutaneously implanted glioma with a herpes simplex virus-defective vector expressing interferon-gamma.
Kanno H; Hattori S; Sato H; Murata H; Huang FH; Hayashi A; Suzuki N; Yamamoto I; Kawamoto S; Minami M; Miyatake S; Shuin T; Kaplitt MG
Cancer Gene Ther; 1999; 6(2):147-54. PubMed ID: 10195881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
